Doug Penner

Langley dad disappointed after bid for medication approval denied

The FDA chose to not approve a drug that, according to Cam Penner, makes a huge difference in his son Doug’s life.

Langley’s Cam Penner’s efforts to help his 13-year-old son Doug, and others with Duchenne muscular dystrophy (DMD), hit a major road block this week.

According to Muscular Dystrophy Canada, DMD is an inherited disorder. The muscles become weaker as the patient gets older.

Doug is also the face behind Ride for Doug, an annual fundraising motorcycle ride organized by Cam.

On Nov. 24, Cam flew to Washington DC, where he addressed the Food and Drug Administration Advisory Committee about the impact that Drisapersen makes on Doug’s daily living.

“The study we have been on since 2011 has finally reached the stage where the FDA needs to either approve or reject it,” Cam explained in mid-December, as he awaited the ruling.

“If approved, other boys with DMD will be able to access the same medication Doug has been taking.”

On Thursday, Cam informed the Langley Advance that the FDA ruled not to approve the drug at this time.

“No reasons for this decision have been released,” Cam said.

The drug company BioMarin has issued a press release that current studies will continue for now.

This means Doug will still get his Drisapersen.

“Thank you BioMarin,” Cam said.

According to BioMarin, Duchenne affects approximately one in every 3,500 to 5,000 male children, making it the most common fatal genetic disorder diagnosed in childhood.

There is currently no FDA-approved therapy designed specifically to treat Duchenne.

For now, Cam said, he and others supporting the use of the drug do not know what is happening next.

“Drisapersen is under review by the EU equivalent of the FDA,” Cam said. “There is no timeline on if or when Canada will be included.”

While extremely disappointing for the Duchenne community, Cam said “our Medical Explorer will continue with his weekly treatments while we watch and pray that we continue to see its benefits.”

Prior to the ruling, Cam said a rejection “may spell the end to Drisapersen, and leave DMD boys with exactly zero approved treatments.”

As with all experimental medications, there have been risks, side effects, and confusing data, Cam explained.

“The FDA is wading through all of these issues and deliberating whether or not to allow access to this drug,” he said last month. “At this point in time, there are no other approved treatments for DMD. None.”

Link to the BioMarin press release here.

Just Posted

Langley Cruise-In makes some changes for second year in Aldergrove

The annual car show will adjust its site and brings in a new “guest star.”

Housing vote a no-go in Langley until autumn

There is no vote planned on the Langley supportive housing project.

VIDEO: Langley couple reunite with Tugger three years after his disappearance

A purebred Pomeranian is back with his parents, likely after years in a puppy mill.

Educational videos for rodeo athletes address concussions, mental health

Ty Pozzobon Foundation, Canadian Pro Sports Medicine Team produce series

Lower Mainland cools down as heat wave lifts

Environment Canada predicts temperatures in the mid to low 20s

Stolen sunshade puts damper on Lower Mainland woman’s pet-relief effort

Broken umbrella taken from White Rock lawn ‘within 10 minutes’

‘Amazing Race Canada’ competitors face B.C. challenge

They drove Corvettes, mastered falconry basics, and ate blueberry pie in the Cowichan Valley

Teen killed by train remembered for his love

Friends and family share stories of young Crescent Beach train victim

Grizzly bear jumps in river, chases B.C. kayaker

The bear got a bit too close for comfort along the Elaho River near Squamish

Parks Canada looks to shine light on cloudy future for historic sites

A plan is in place to produce 10-year plans designed to turn around sagging attendance figures

Island man convicted of 1999 sex assault at Fraser Valley music festival

James Allen Redden, formerly of Nanaimo, was found guilty of three charges

B.C. poet shines a bright light on struggle with homelessness

Book launch for John La Greca’s Homeless Memorial is at Vernon’s Gallery Vertigo July 21.

Ontario police say attack on Muslim man was motivated by hate

Two men, aged 27 and 19, have been charged with assault in the incident

Canadian Tire delivers toys to ease kids’ street play pain in B.C. neighbourhood

It’s like Christmas for 11 kids who are supposed to be confined to their yards by strata bylaw

Most Read